Recently Viewed 0
Home Buprenorphine API CS-O-00994

Buprenorphine

RFQ Review Required

Buprenorphine

API · API Family: Buprenorphine · CAT No. CS-O-00994 · CAS No. 52485-79-7 · Controlled Product
Controlled Product - RFQ Review Required

This is a controlled substance entry for enquiry only. Please add this item to your RFQ basket so the requirement can be reviewed for end-use, organization details, certifications, permits, documentation and applicable legal requirements before any possible supply discussion.

Added to RFQ
Controlled substance entry. Enquiry is subject to due diligence, certification, documentation and applicable compliance review. For Research & Analytical Purposes only. Not for personal use.
Clearsynth product packaging

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.

Buprenorphine Product Information

Buprenorphine is listed under API and is intended for research and analytical applications. It is associated with Buprenorphine. This is a controlled substance entry for enquiry only. Any possible supply discussion is subject to due diligence, certification, permits, documentation, intended end-use and applicable compliance review.

This controlled substance entry is shown for qualified research enquiry and compliance review, with product information including CAS number, molecular formula, molecular weight and enquiry details.

Technical Data

Product Name
Buprenorphine
CAS No.
52485-79-7
CAT No.
CS-O-00994
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C29H41NO4
Molecular Weight
467.64 g/mol
Category
API Family
Storage Condition
Refer MSDS for complete information.
Controlled Product
Yes - enquiry is subject to RFQ review, due diligence, certification, documentation and applicable compliance requirements.
Hazard Compound
Refer MSDS for accurate information.

Description

Regulatory Description
Buprenorphine is a controlled substance reference entry. Enquiries are reviewed for organization details, intended end-use, certifications, permits, documentation and applicable legal requirements before any possible supply discussion.
Overview
A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activ
Synonyms
Buprenorphine
Application Notes
A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activ
References

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Enquire 52485-79-752485-79-7 controlled substance reference entry52485-79-7 compliance reviewEnquire BuprenorphineBuprenorphine controlled substance reference entryBuprenorphine RFQ compliance reviewBuprenorphine analytical research enquiryBuprenorphine due diligence reviewBuprenorphine Reference Standard
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.